HALO
Halozyme Therape (HALO)
NASDAQ
$124.55+$0.005 (+0.004%)
Price as of Oct 22, 2026 7:43 PM EDT
  • $14.2B
    Market Cap
  • 86.20%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$124.54
Change
-$0.29 (-0.23%)
Open
$124.72
High
$124.91
Low
$121.62
Previous Close
$124.83
Volume
5,097,642
30-Day Average Volume
2,546,656
1-Week Change
2.49%
1-Month Change
8.17%
1-Year Change
86.20%
3-Year Change
254.21%
5-Year Change
220.40%
Fundamentals
Shares Outstanding
113.5M
Total Assets
$2.6B
Market Cap
$14.2B
Enterprise Value
$16.2B
Period:
QTR
TTM
FY
Revenue
$307.7M
Net Income
$229.9M
Free Cash Flow
$236.7M
EBIT
$285.3M
EBITDA
$314.8M
Net Working Capital
$588.6M
EPS
$1.90
Enterprise Value/EBITDA
51
Enterprise Value/Revenue
52
P/B
99
P/E
66
PEG
1
Price/Free Cash Flow
60
Price/Operating Cash Flow
59
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue